Apures Co., Ltd. (XKON:149300)

South Korea flag South Korea · Delayed Price · Currency is KRW
205.00
-10.00 (-4.65%)
At close: Aug 22, 2025, 3:30 PM KST
-4.65%
Market Cap9.32B
Revenue (ttm)517.33M
Net Income (ttm)-3.73B
Shares Out45.49M
EPS (ttm)-138.55
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume197,602
Average Volume93,975
Open244.00
Previous Close215.00
Day's Range194.00 - 244.00
52-Week Range41.00 - 487.00
Beta-0.58
RSI88.68
Earnings Daten/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transpl... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 149300
Full Company Profile

Financial Performance

In 2018, Apures's revenue was 528.64 million, an increase of 28.45% compared to the previous year's 411.56 million. Losses were -4.68 billion, -16.82% less than in 2017.

Financial Statements

News

There is no news available yet.